<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04742855</url>
  </required_header>
  <id_info>
    <org_study_id>01/2021</org_study_id>
    <nct_id>NCT04742855</nct_id>
  </id_info>
  <brief_title>Probiotics for Blepharitis in Adults and Children</brief_title>
  <official_title>Effect of Probiotics on the Occurrence of Blepharitis in Adults and Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Molise</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Molise</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The alteration of the intestinal microbiota through the use of specific probiotics can&#xD;
      improve the clinical course of blepharitis by restoring intestinal and immune homeostasis.&#xD;
      The purpose of this study is to define the possible positive impact of probiotics on patients&#xD;
      with blepharitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From recent studies, it has emerged that the gut microbiota is a possible responsible for the&#xD;
      stimulation of the innate immune response and its role in the pathogenesis of autoimmune&#xD;
      diseases has been deepened. Several clinical studies, in fact, support the existence of a&#xD;
      connection between changes in the commensal intestinal microbiota (&quot;dysbiosis&quot;) and&#xD;
      autoimmune diseases. It has been seen that also ocular conditions like chalaziosis and&#xD;
      uveitis are tied to dysbiosis. In addition, in a recent study probiotics were found to be&#xD;
      safe and effective in the treatment of chalaziosis in children. Other eye conditions that may&#xD;
      be affected by changes in the gut microbiome are dry eye syndrome and blepharitis. Under&#xD;
      these conditions, a reduction in globet cells has often been noted. These cells produce the&#xD;
      mucins present on the ocular surface, and therefore, their reduction involves the production&#xD;
      of a thin and ineffective tear film. Therefore, the study will cover patients with&#xD;
      blepharitis (both adults and children), treated with specific probiotics to be taken daily.&#xD;
      Patients will then undergo a full ophthalmological examination each week for the first month,&#xD;
      and then monthly until complete recovery for at least 6 months. In addition, at the time of&#xD;
      enlistment and complete recovery, after venous sampling, the following biomarkers will be&#xD;
      analyzed with cytometer and ELISA: TNFα and lymphocyte subpopulations. With this study,&#xD;
      therefore, the aim is to define the possible positive impact of probiotics on patients with&#xD;
      blepharitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2021</start_date>
  <completion_date type="Anticipated">January 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 18, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blepharitis recurrence</measure>
    <time_frame>six months</time_frame>
    <description>assessment of the number of recurrences during the time frame of the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blepharitis resolution time</measure>
    <time_frame>six months</time_frame>
    <description>assessment of the number of days required for full resolution of the blepharitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>systemic inflammatory profile</measure>
    <time_frame>six months</time_frame>
    <description>After venous sampling, the following biomarker will be analysed with a cytometer: TNFα (pg/mL) .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systemic inflammatory profile</measure>
    <time_frame>six months</time_frame>
    <description>After venous sampling, the following biomarker will be analysed with a cytometer: lymphocyte subpopulations (cells/mcL).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Blepharitis</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>It will consist of 10 adults and 5 children. They will get the yogurt strains</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>It will consist of 10 adults and 5 children. They will get the Bifidobacterium strains.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <description>It will consist of 10 adults and 5 children. They will get the placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <description>Study product is packaged as powders in a sachet. Participants and their parents will be instructed to dissolve the powder in water or milk, and to drink it in the morning and/or evening.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients with blepharitis will be divided into three groups of 15 each (each group will&#xD;
        be composed of 10 adults and 5 children)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  blepharitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  eyelid infection&#xD;
&#xD;
          -  suspicion of malignancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Molise</name>
      <address>
        <city>Campobasso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Costagliola Ciro</last_name>
      <phone>08744092269</phone>
      <email>ciro.costagliola@unimol.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Lu LJ, Liu J. Human Microbiota and Ophthalmic Disease. Yale J Biol Med. 2016 Sep 30;89(3):325-330. eCollection 2016 Sep. Review.</citation>
    <PMID>27698616</PMID>
  </results_reference>
  <results_reference>
    <citation>Floyd JL, Grant MB. The Gut-Eye Axis: Lessons Learned from Murine Models. Ophthalmol Ther. 2020 Sep;9(3):499-513. doi: 10.1007/s40123-020-00278-2. Epub 2020 Jul 2. Review.</citation>
    <PMID>32617914</PMID>
  </results_reference>
  <results_reference>
    <citation>Moon J, Yoon CH, Choi SH, Kim MK. Can Gut Microbiota Affect Dry Eye Syndrome? Int J Mol Sci. 2020 Nov 10;21(22). pii: E8443. doi: 10.3390/ijms21228443. Review.</citation>
    <PMID>33182758</PMID>
  </results_reference>
  <results_reference>
    <citation>Filippelli M, dell'Omo R, Amoruso A, Paiano I, Pane M, Napolitano P, Bartollino S, Costagliola C. Intestinal microbiome: a new target for chalaziosis treatment in children? Eur J Pediatr. 2021 Apr;180(4):1293-1298. doi: 10.1007/s00431-020-03880-5. Epub 2020 Nov 23.</citation>
    <PMID>33226501</PMID>
  </results_reference>
  <results_reference>
    <citation>Ochoa-Repáraz J, Kasper LH. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease. Transl Res. 2017 Jan;179:126-138. doi: 10.1016/j.trsl.2016.07.016. Epub 2016 Jul 28. Review.</citation>
    <PMID>27519147</PMID>
  </results_reference>
  <results_reference>
    <citation>Cavuoto KM, Banerjee S, Galor A. Relationship between the microbiome and ocular health. Ocul Surf. 2019 Jul;17(3):384-392. doi: 10.1016/j.jtos.2019.05.006. Epub 2019 May 21. Review.</citation>
    <PMID>31125783</PMID>
  </results_reference>
  <results_reference>
    <citation>Moon J, Choi SH, Yoon CH, Kim MK. Gut dysbiosis is prevailing in Sjögren's syndrome and is related to dry eye severity. PLoS One. 2020 Feb 14;15(2):e0229029. doi: 10.1371/journal.pone.0229029. eCollection 2020.</citation>
    <PMID>32059038</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Molise</investigator_affiliation>
    <investigator_full_name>Ciro Costagliola</investigator_full_name>
    <investigator_title>Full Professor in Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>microbiome/microbiota</keyword>
  <keyword>probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blepharitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

